SCHEMBL2926066

SCHEMBL2926066

[CH2]c1ccc(CCCCCCCCC)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.63
ADRA2A P08913 2/20 0.63
ADORA3 P0DMS8 2/20 0.63
TACR2 P21452 2/20 0.63
SLC6A2 P23975 2/20 0.63
SLC6A4 P31645 2/20 0.63
SLC6A3 Q01959 2/20 0.63
ALDH1A1 P00352 2/20 0.63
HSD17B10 Q99714 2/20 0.63
KDM4E B2RXH2 1/20 0.63
LMNA P02545 1/20 0.63
SHBG P04278 1/20 0.63
TP53 P04637 1/20 0.63
CYP3A4 P08684 1/20 0.63
HSPD1 P10809 1/20 0.63
ADRB3 P13945 1/20 0.63
HTR2C P28335 1/20 0.63
HSPE1 P61604 1/20 0.63
HIF1A Q16665 1/20 0.63
TST Q16762 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412588 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL1613195 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL1006220 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL7929651 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL23754723 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL11096868 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL23754712 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL7335623 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL23755035 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL1119534 1.00 ESR1 (0.63) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097980-B1 Bathophenanthroline compound and process for preparing same SONY CORP (JP) 2012-07-04 EP claimed
US-7847117-B2 Process for preparing alkyl(methoxymethyl)trimethylsilanylmethylamines WACKER CHEMIE AG (DE) 2010-12-07 US claimed
EP-2050754-B1 Method for manufacturing alkyl-methoxymethyl-trimethylsilanylmethyl amines WACKER CHEMIE AG (DE) 2010-09-15 EP claimed
EP-2050754-A1 Method for manufacturing alkyl-methoxymethyl-trimethylsilanylmethyl amines Wacker Chemie AG (DE) 2009-04-22 EP claimed
US-20090036700-A1 Process For Preparing Alkyl(Methoxymethyl)Trimethylsilanylmethylamines WACKER CHEMIE AG (DE) 2009-02-05 US claimed
US-7186469-B2 Bathophenanthroline compound and EL device SONY CORPORATION (JP) 2007-03-06 US claimed
US-6972334-B1 Bathophenathroline compound and process for preparing same SONY CORPORATION (JP) 2005-12-06 US claimed
US-20040265626-A1 Optical recording medium JOLED INC. (JP) 2004-12-30 US claimed
US-11678571-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 US disclosed
US-20210376247-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE IDEMITSU KOSAN CO., LTD. (JP) 2021-12-02 US disclosed
US-11152574-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle IDEMITSU KOSAN CO., LTD. (JP) 2021-10-19 US disclosed
US-11094888-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle IDEMITSU KOSAN CO., LTD. (JP) 2021-08-17 US disclosed
US-20210083194-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE IDEMITSU KOSAN CO., LTD. (JP) 2021-03-18 US disclosed
CN-105008999-B Electrophotographic photosensitive element, handle box, electronic photographing device and condensed polycyclc aromatic compound 佳能株式会社 2019-05-17 CN disclosed
EP-0226545-A1 Substituted aminoxyethyl phosphonates CIBA-GEIGY AG (CH) 1987-06-24 EP disclosed
EP-0073007-B1 METHOD FOR THE SQUARE DIMENSIONAL CONCENTRATION OF LIGHT, AND FLUORESCENT COMPOUNDS BASF Aktiengesellschaft (DE) 1984-12-27 EP disclosed
US-4486587-A LIGHFASTNESS, THEROMOSTABILITY BASF AKTIENGESELLSCHAFT (DE) 1984-12-04 US disclosed
EP-0073007-A1 Method for the square dimensional concentration of light, and fluorescent compounds BASF Aktiengesellschaft (DE) 1983-03-02 EP disclosed
US-4238613-A IMPARTING PHOTOSTABILITY AND OXIDATION AND HEAT RESISTANCE TO PLASTICS CIBA-GEIGY CORPORATION (US) 1980-12-09 US disclosed
US-3945824-A HETEROCYCLIC COMPOUND, PHOTOGRAPHIC MATERIAL FUJI PHOTO FILM CO., LTD. (JA) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11152574-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle RPL21, RPS21, AOC2 ESR1 374/4885ADRA2A 877/4885ADORA3 2049/4885
US-11678571-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle RPS17, RPS19, CDK17 ESR1 410/4885ADRA2A 1244/4885ADORA3 213/4885
US-20090036700-A1 Process For Preparing Alkyl(Methoxymethyl)Trimethylsilanylmethylamines PNMT, TET2, HNMT ESR1 3809/4885ADRA2A 570/4885ADORA3 3517/4885
US-20210083194-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE RPL21, RPS21, AOC2 ESR1 374/4885ADRA2A 877/4885ADORA3 2049/4885
US-11094888-B2 Organic electroluminescent device using aryl amine derivative containing heterocycle SLC18A1, SLC18A2, AOC2 ESR1 343/4885ADRA2A 928/4885ADORA3 735/4885
US-20210376247-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE RPS17, RPS19, CDK17 ESR1 410/4885ADRA2A 1244/4885ADORA3 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.